Company Filing History:
Years Active: 2020
Title: Shungo Takeuchi: Innovator in Polymerized Peptide Technology
Introduction
Shungo Takeuchi is a prominent inventor based in Tokyo, Japan. He is known for his innovative work in the field of polymerized peptides, particularly those with collagen-like structures. His contributions to the field have significant implications for regenerative medicine and biotechnology.
Latest Patents
Shungo Takeuchi holds a patent for a polymerized peptide and gel that possesses a collagen-like structure. This invention is produced by oxidatively cross-linking collagen-like peptides that have a triple-helical structure, which includes three peptide chains, each containing multiple cysteine (Cys) residues. The polymerized peptide can be processed into a hydrogel and a thin membrane sheet, making it versatile for various applications. It is capable of imparting specific physiological functions, such as cellular adhesion, by incorporating functional amino acid sequences found in biological polymers. The patent also outlines a method for producing this polymerized peptide and its applications, including cell culturing, wound dressing, and the development of regenerative medical materials and research materials.
Career Highlights
Shungo Takeuchi is associated with Kola-gen Pharma, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of biotechnology, particularly in the development of materials that can enhance healing and tissue regeneration.
Collaborations
Shungo Takeuchi has collaborated with notable colleagues, including Takaki Koide and Shinichiro Ichise. These collaborations have further enriched his research and contributed to the advancement of innovative solutions in the field.
Conclusion
Shungo Takeuchi's contributions to the field of polymerized peptides highlight his role as an innovator in biotechnology. His patented work has the potential to revolutionize applications in regenerative medicine and beyond.